AU2001276306A1 - Use of dicalcium phosphate anhydride powder - Google Patents
Use of dicalcium phosphate anhydride powderInfo
- Publication number
- AU2001276306A1 AU2001276306A1 AU2001276306A AU7630601A AU2001276306A1 AU 2001276306 A1 AU2001276306 A1 AU 2001276306A1 AU 2001276306 A AU2001276306 A AU 2001276306A AU 7630601 A AU7630601 A AU 7630601A AU 2001276306 A1 AU2001276306 A1 AU 2001276306A1
- Authority
- AU
- Australia
- Prior art keywords
- dicalcium phosphate
- phosphate anhydride
- anhydride powder
- mum
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000019739 Dicalciumphosphate Nutrition 0.000 title abstract 2
- 239000001506 calcium phosphate Substances 0.000 title abstract 2
- 229940038472 dicalcium phosphate Drugs 0.000 title abstract 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 title abstract 2
- -1 dicalcium phosphate anhydride Chemical class 0.000 title abstract 2
- 239000000843 powder Substances 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Dicalcium phosphate anhydride powder of which at least 50% by weight is of a grain size of between 45 and 150 mum, a maximum of 50% by weight is of a grain size of <45 mum and a maximum of 5% by weight is of a grain size >150 mum and which has a bulk density of between 1000 and 1500 g/l and a specific surface area of <5 m2/g is used for direct tabletting or capsule filling of pharmaceutical preparations.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10032434A DE10032434A1 (en) | 2000-07-04 | 2000-07-04 | Use of dicalcium phosphate anhydride powder |
DE10032434 | 2000-07-04 | ||
PCT/DE2001/002484 WO2002002082A2 (en) | 2000-07-04 | 2001-06-29 | Use of dicalcium phosphate anhydride powder |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001276306A1 true AU2001276306A1 (en) | 2002-01-14 |
Family
ID=7647722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001276306A Abandoned AU2001276306A1 (en) | 2000-07-04 | 2001-06-29 | Use of dicalcium phosphate anhydride powder |
Country Status (8)
Country | Link |
---|---|
US (2) | US7691410B2 (en) |
EP (1) | EP1296654B1 (en) |
AT (1) | ATE334661T1 (en) |
AU (1) | AU2001276306A1 (en) |
CA (1) | CA2413578C (en) |
DE (2) | DE10032434A1 (en) |
DK (1) | DK1296654T3 (en) |
WO (1) | WO2002002082A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8375896B2 (en) | 2010-10-14 | 2013-02-19 | Gaines B. Slade, JR. | Method of use of dicalcium phosphate as an antler scent |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2220474A1 (en) * | 1973-03-09 | 1974-10-04 | Ugine Kuhlmann | Highly absorbent calcium phosphate for animal feeds - in the form of granules or compacted grains of specified porosity |
DE3347476A1 (en) * | 1982-12-29 | 1984-07-05 | Lion Corp., Tokio / Tokyo | DENTAL CARE AND SUITABLE ABRASIVE |
US4707361A (en) * | 1985-08-02 | 1987-11-17 | Stauffer Chemical Company | Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
US4675188A (en) * | 1985-08-02 | 1987-06-23 | Stauffer Chemical Company | Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
US4721615A (en) * | 1986-05-05 | 1988-01-26 | Monsanto Company | Calcium phosphates |
JPS63103809A (en) * | 1986-10-22 | 1988-05-09 | Agency Of Ind Science & Technol | Production of porous calcium phosphate sphere |
US5055307A (en) * | 1988-12-29 | 1991-10-08 | Asahi Kagaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
DE4122960C2 (en) * | 1991-07-11 | 1994-03-31 | Benckiser Knapsack Ladenburg | Process for the preparation of coarse-grained dicalcium phosphate anhydride |
JP2700141B2 (en) * | 1993-09-17 | 1998-01-19 | 富士化学工業株式会社 | Calcium hydrogen phosphate, its production method and excipient using the same |
KR20010012402A (en) * | 1997-05-09 | 2001-02-15 | 세이지 파마슈티칼스, 인크. | Stable oral pharmaceutical dosage forms |
EP1008353A1 (en) * | 1998-04-24 | 2000-06-14 | Fuji Chemical Industry Co., Ltd. | Saccharide-containing compositions |
WO2003055418A1 (en) * | 2001-12-21 | 2003-07-10 | Lagow Richard J | Calcium phosphate bone replacement materials and methods of use thereof |
US7364755B2 (en) * | 2003-07-07 | 2008-04-29 | Synthon Ip Inc. | Modified calcium phosphate excipient |
-
2000
- 2000-07-04 DE DE10032434A patent/DE10032434A1/en not_active Withdrawn
-
2001
- 2001-06-29 EP EP01953861A patent/EP1296654B1/en not_active Expired - Lifetime
- 2001-06-29 DK DK01953861T patent/DK1296654T3/en active
- 2001-06-29 WO PCT/DE2001/002484 patent/WO2002002082A2/en active IP Right Grant
- 2001-06-29 US US10/332,106 patent/US7691410B2/en active Active
- 2001-06-29 AT AT01953861T patent/ATE334661T1/en not_active IP Right Cessation
- 2001-06-29 CA CA002413578A patent/CA2413578C/en not_active Expired - Lifetime
- 2001-06-29 AU AU2001276306A patent/AU2001276306A1/en not_active Abandoned
- 2001-06-29 DE DE50110628T patent/DE50110628D1/en not_active Expired - Lifetime
-
2010
- 2010-02-17 US US12/706,985 patent/US8501235B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE334661T1 (en) | 2006-08-15 |
EP1296654B1 (en) | 2006-08-02 |
DE10032434A1 (en) | 2002-01-24 |
CA2413578C (en) | 2009-02-10 |
EP1296654A2 (en) | 2003-04-02 |
CA2413578A1 (en) | 2002-01-10 |
WO2002002082A2 (en) | 2002-01-10 |
US20100144894A1 (en) | 2010-06-10 |
US8501235B2 (en) | 2013-08-06 |
DK1296654T3 (en) | 2006-08-28 |
WO2002002082A3 (en) | 2002-06-27 |
US7691410B2 (en) | 2010-04-06 |
DE50110628D1 (en) | 2006-09-14 |
US20040013724A1 (en) | 2004-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203841A3 (en) | 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them | |
EP0433842A3 (en) | 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them | |
AU5936400A (en) | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same | |
AU2613995A (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
HK1037975A1 (en) | Two-piece capsule for receiving pharmaceutical preparations for powder inhalers. | |
CA2294783A1 (en) | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin | |
CA2292673A1 (en) | Pharmaceutical compositions containing eletriptan hemisulphate | |
TW280774B (en) | ||
HUP0203376A3 (en) | 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them and their use | |
HU229443B1 (en) | Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use | |
CA2000763A1 (en) | Dispersable formulation | |
HUP0003207A3 (en) | Proliposome powders for inhalation stabilised by tocopherol, pharmaceutical compositions containing the same and the use of them | |
AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
AU2001276306A1 (en) | Use of dicalcium phosphate anhydride powder | |
CA2250191A1 (en) | Benzothiophenes, formulations containing same, and methods | |
AU4531499A (en) | Fine powder of l-alpha-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders | |
HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
AU4929400A (en) | Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof | |
CA2255064A1 (en) | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations | |
BG106151A (en) | Pharmaceutical complex | |
AU4483693A (en) | Solid oral tablet formulations of ifosfamide | |
PL345309A1 (en) | Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient | |
AU3416995A (en) | Endothelin receptor antagonists | |
CA2382359A1 (en) | Pharmaceutical preparation containing nanosol |